Atorvastatin Pre-Treatment Study In Asian Patients With Acute Coronary Syndrome

NCT00728988 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

499

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DRUG: Atorvastatin
DRUG: Atorvastatin

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.